Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 44 Breast Neoplasms 33 Neoplasms 31 Melanoma 24 Neoplasm Metastasis 22 Leukemia, Myeloid, Acute 21 Colorectal Neoplasms 18 Prostatic Neoplasms 17 Multiple Myeloma 17 Lung Neoplasms 17 Ovarian Neoplasms 14 Myelodysplastic Syndromes 13 Squamous Cell Carcinoma of Head and Neck 12 Recurrence 12 Lymphoma, Non-Hodgkin 12 Carcinoma, Renal Cell 11 Uterine Cervical Neoplasms 10 Urinary Bladder Neoplasms 10 Pancreatic Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 10 Glioblastoma 10 Brain Neoplasms 10 Carcinoma, Hepatocellular 9 Stomach Neoplasms 8 Triple Negative Breast Neoplasms 7 Rectal Neoplasms 7 Lymphoma 7 Hodgkin Disease 7 Head and Neck Neoplasms 7 Glioma 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Malignancies × 90 days × Clear all

NCT05351697 2026-03-17

BR105-I

BioRay Pharmaceutical Co., Ltd.

Phase 1 Terminated

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡